Trial Profile
A randomised phase IIb trial with ETBX 011
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 May 2013
Price :
$35
*
At a glance
- Drugs ETBX 011 (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 09 May 2013 New trial record